Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Daniel Jonas. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Daniel Jonas har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:CNMD / CONMED Corporation | Special Counsel & Corp Secy | 13 462 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Daniel Jonas. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp CNMD / CONMED Corporation - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CNMD / CONMED Corporation. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CNMD / CONMED Corporation. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Daniel Jonas som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-05-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −200 | 13 462 | −1,46 | 127,56 | −25 512 | 1 717 213 | |
2023-05-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −4 300 | 13 662 | −23,94 | 126,72 | −544 896 | 1 731 249 | |
2023-05-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −5 500 | 17 962 | −23,44 | 125,57 | −690 635 | 2 255 488 | |
2023-05-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 10 000 | 23 462 | 74,28 | 97,69 | 976 900 | 2 292 003 | |
2023-05-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
G - Gift | −626 | 13 462 | −4,44 | ||||
2023-04-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 40 | 14 088 | 0,28 | 98,67 | 3 947 | 1 390 063 | |
2023-03-03 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −5 000 | 14 048 | −26,25 | 96,08 | −480 381 | 1 349 678 | |
2023-03-03 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 5 000 | 19 048 | 35,59 | 78,76 | 393 800 | 1 500 220 | |
2023-03-03 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −5 400 | 14 048 | −27,77 | 96,24 | −519 723 | 1 352 050 | |
2023-03-03 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 5 400 | 19 448 | 38,44 | 59,96 | 323 784 | 1 166 102 | |
2023-03-03 |
|
4 | CNMD |
CONMED Corp
Common Stock |
F - Taxes | −736 | 14 048 | −4,98 | 96,16 | −70 774 | 1 350 856 | |
2023-03-03 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 2 500 | 14 784 | 20,35 | ||||
2023-01-10 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 24 | 12 284 | 0,20 | 84,21 | 2 021 | 1 034 436 | |
2022-10-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 26 | 12 260 | 0,21 | 76,16 | 1 980 | 933 722 | |
2022-07-06 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 22 | 12 234 | 0,18 | 90,97 | 2 001 | 1 112 927 | |
2022-04-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 45 | 12 212 | 0,37 | 141,12 | 6 350 | 1 723 357 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −11 157 | 10 000 | −52,73 | ||||
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −5 600 | 5 400 | −50,91 | ||||
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −3 610 | 0 | −100,00 | ||||
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −1 390 | 3 610 | −27,80 | ||||
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −11 157 | 12 167 | −47,83 | 142,50 | −1 589 872 | 1 733 798 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 11 157 | 23 324 | 91,70 | 78,76 | 878 725 | 1 836 998 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −5 600 | 12 167 | −31,52 | 142,50 | −798 000 | 1 733 798 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 5 600 | 17 767 | 46,03 | 59,96 | 335 776 | 1 065 309 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −3 610 | 12 167 | −22,88 | 142,42 | −514 141 | 1 732 841 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 3 610 | 15 777 | 29,67 | 41,93 | 151 367 | 661 530 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −1 390 | 12 167 | −10,25 | 143,30 | −199 181 | 1 743 482 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 1 390 | 13 557 | 11,42 | 41,93 | 58 283 | 568 445 | |
2022-03-03 |
|
4 | CNMD |
CONMED Corp
Rsus (restricted Stock Units) |
A - Award | 2 500 | 2 500 | |||||
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −3 755 | 20 000 | −15,81 | ||||
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −1 245 | 23 755 | −4,98 | ||||
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −3 343 | 21 157 | −13,64 | ||||
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −500 | 24 500 | −2,00 | ||||
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −3 755 | 12 167 | −23,58 | 149,46 | −561 206 | 1 818 428 | |
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 3 755 | 15 922 | 30,86 | 97,69 | 366 826 | 1 555 420 | |
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −1 245 | 12 167 | −9,28 | 150,00 | −186 750 | 1 825 050 | |
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 1 245 | 13 412 | 10,23 | 97,69 | 121 624 | 1 310 218 | |
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −3 343 | 12 167 | −21,55 | 149,41 | −499 482 | 1 817 886 | |
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 3 343 | 15 510 | 27,48 | 78,76 | 263 295 | 1 221 568 | |
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −500 | 12 167 | −3,95 | 150,03 | −75 015 | 1 825 424 | |
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 500 | 12 667 | 4,11 | 78,76 | 39 380 | 997 653 | |
2022-02-04 |
|
5 | CNMD |
CONMED Corp
Common Stock |
J - Other | −450 | 450 | −50,00 | ||||
2022-01-05 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 14 | 12 167 | 0,12 | 134,67 | 1 885 | 1 638 530 | |
2021-10-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 16 | 12 153 | 0,13 | 124,29 | 1 989 | 1 510 496 | |
2021-09-17 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −11 000 | 11 000 | −50,00 | ||||
2021-09-17 |
|
4 | CNMD |
CONMED Corp
Common Stock |
G - Gift | −1 000 | 12 137 | −7,61 | ||||
2021-09-17 |
|
4 | CNMD |
CONMED Corp
Common Stock |
F - Taxes | −8 327 | 13 137 | −38,80 | 127,56 | −1 062 192 | 1 675 756 | |
2021-09-17 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 11 000 | 21 464 | 105,12 | 59,96 | 659 560 | 1 286 981 | |
2021-09-17 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −3 357 | 10 464 | −24,29 | 127,26 | −427 202 | 1 331 618 | |
2021-07-06 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 15 | 13 821 | 0,11 | 130,56 | 1 958 | 1 804 470 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −4 176 | 5 000 | −45,51 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −4 176 | 13 806 | −23,22 | 145,59 | −607 986 | 2 010 024 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 4 176 | 17 982 | 30,25 | 41,93 | 175 100 | 753 985 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −5 000 | 22 000 | −18,52 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −10 000 | 9 176 | −52,15 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −700 | 19 176 | −3,52 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −5 000 | 13 806 | −26,59 | 142,00 | −710 000 | 1 960 452 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 5 000 | 18 806 | 36,22 | 59,96 | 299 800 | 1 127 608 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −10 000 | 13 806 | −42,01 | 141,08 | −1 410 750 | 1 947 681 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 10 000 | 23 806 | 72,43 | 41,93 | 419 300 | 998 186 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −100 | 13 806 | −0,72 | 143,30 | −14 330 | 1 978 400 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −600 | 13 906 | −4,14 | 142,58 | −85 549 | 1 982 731 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 700 | 14 506 | 5,07 | 41,93 | 29 351 | 608 237 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −4 176 | 5 000 | −45,51 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −4 176 | 13 806 | −23,22 | 145,59 | −607 986 | 2 010 024 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 4 176 | 17 982 | 30,25 | 41,93 | 175 100 | 753 985 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −5 000 | 22 000 | −18,52 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −10 000 | 9 176 | −52,15 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −700 | 19 176 | −3,52 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −5 000 | 13 806 | −26,59 | 142,00 | −710 000 | 1 960 452 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 5 000 | 18 806 | 36,22 | 59,96 | 299 800 | 1 127 608 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −10 000 | 13 806 | −42,01 | 141,08 | −1 410 750 | 1 947 681 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 10 000 | 23 806 | 72,43 | 41,93 | 419 300 | 998 186 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −100 | 13 806 | −0,72 | 143,30 | −14 330 | 1 978 400 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −600 | 13 906 | −4,14 | 142,58 | −85 549 | 1 982 731 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 700 | 14 506 | 5,07 | 41,93 | 29 351 | 608 237 | |
2021-04-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 43 | 13 806 | 0,31 | 124,06 | 5 335 | 1 712 772 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −1 000 | 19 876 | −4,79 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −2 199 | 0 | −100,00 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | 150 | 450 | 50,00 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −150 | 13 763 | −1,08 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −150 | 13 763 | −1,08 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −800 | 14 063 | −5,38 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −1 000 | 14 863 | −6,30 | 121,92 | −121 919 | 1 812 088 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 000 | 15 863 | 6,73 | 41,93 | 41 930 | 665 136 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 199 | 14 863 | −12,89 | 121,84 | −267 934 | 1 810 963 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 199 | 17 062 | 14,80 | 39,87 | 87 674 | 680 262 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 21 250 | 21 250 | |||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −3 500 | 20 876 | −14,36 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −624 | 24 376 | −2,50 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −3 221 | 2 199 | −59,43 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −2 345 | 14 863 | −13,63 | 123,20 | −288 904 | 1 831 122 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 3 500 | 17 208 | 25,53 | 41,93 | 146 755 | 721 531 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −624 | 13 708 | −4,35 | 123,28 | −76 924 | 1 689 856 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 624 | 14 332 | 4,55 | 41,93 | 26 164 | 600 941 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −3 221 | 13 708 | −19,03 | 123,26 | −397 019 | 1 689 643 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 3 221 | 16 929 | 23,50 | 39,87 | 128 421 | 674 959 | |
2020-11-20 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −2 680 | 5 420 | −33,09 | ||||
2020-11-20 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −2 000 | 8 100 | −19,80 | ||||
2020-11-20 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 680 | 13 708 | −16,35 | 101,00 | −270 680 | 1 384 508 | |
2020-11-20 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 680 | 16 388 | 19,55 | 39,87 | 106 852 | 653 390 | |
2020-11-20 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 000 | 13 708 | −12,73 | 100,50 | −201 006 | 1 377 695 | |
2020-11-20 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 15 708 | 14,59 | 39,87 | 79 740 | 626 278 | |
2020-11-18 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −5 000 | 10 100 | −33,11 | ||||
2020-11-18 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −5 000 | 13 708 | −26,73 | 96,12 | −480 587 | 1 317 577 | |
2020-11-18 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 5 000 | 18 708 | 36,48 | 39,87 | 199 350 | 745 888 | |
2020-11-12 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −4 960 | 0 | −100,00 | ||||
2020-11-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −3 832 | 13 708 | −21,85 | 94,08 | −360 515 | 1 289 649 | |
2020-11-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 4 960 | 17 540 | 39,43 | 51,30 | 254 448 | 899 802 | |
2020-08-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −600 | 12 580 | −4,55 | ||||
2020-08-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | 100 | 300 | 50,00 | ||||
2020-08-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −100 | 13 180 | −0,75 | ||||
2020-08-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −4 349 | 13 280 | −24,67 | 82,66 | −359 488 | 1 097 725 | |
2020-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 224 | 17 629 | 1,29 | 54,41 | 12 188 | 959 194 | |
2020-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 25 000 | 25 000 | |||||
2020-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −350 | 0 | −100,00 | ||||
2020-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −175 | 17 405 | −1,00 | 94,64 | −16 562 | 1 647 209 | |
2020-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 350 | 17 580 | 2,03 | ||||
2019-10-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 15 | 17 230 | 0,09 | 91,34 | 1 370 | 1 573 788 | |
2019-08-07 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −1 560 | 0 | −100,00 | ||||
2019-08-07 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −12 000 | 15 100 | −44,28 | ||||
2019-08-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 909 | 17 215 | −14,46 | 92,10 | −267 919 | 1 585 502 | |
2019-08-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 157 | 20 124 | −5,44 | 92,94 | −107 532 | 1 870 325 | |
2019-08-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 560 | 21 281 | 7,91 | 44,90 | 70 044 | 955 517 | |
2019-08-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −8 598 | 19 721 | −30,36 | 92,01 | −791 102 | 1 814 529 | |
2019-08-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 12 000 | 28 319 | 73,53 | 39,87 | 478 440 | 1 129 079 | |
2019-07-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 55 | 16 319 | 0,34 | 81,29 | 4 471 | 1 326 572 | |
2019-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −1 000 | 16 264 | −5,79 | ||||
2019-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −100 | 17 264 | −0,58 | ||||
2019-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −100 | 17 264 | −0,58 | ||||
2019-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | 100 | 200 | 100,00 | ||||
2019-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −650 | 0 | −100,00 | ||||
2019-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −325 | 17 464 | −1,83 | 80,48 | −26 156 | 1 405 503 | |
2019-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 650 | 17 789 | 3,79 | ||||
2019-04-30 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −7 840 | 4 960 | −61,25 | ||||
2019-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −4 000 | 17 139 | −18,92 | 80,51 | −322 050 | 1 379 902 | |
2019-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −6 358 | 21 139 | −23,12 | 82,48 | −524 408 | 1 743 545 | |
2019-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 7 840 | 27 497 | 39,88 | 51,30 | 402 192 | 1 410 596 | |
2019-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 226 | 19 657 | 1,16 | 79,02 | 17 859 | 1 553 296 | |
2019-03-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −350 | 350 | −50,00 | ||||
2019-03-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −1 025 | 0 | −100,00 | ||||
2019-03-05 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 25 000 | 25 000 | |||||
2019-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −116 | 19 431 | −0,59 | 78,76 | −9 136 | 1 530 386 | |
2019-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 350 | 19 547 | 1,82 | ||||
2019-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −399 | 19 197 | −2,04 | 78,76 | −31 425 | 1 511 956 | |
2019-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 025 | 19 596 | 5,52 | ||||
2019-01-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 67 | 18 571 | 0,36 | 60,99 | 4 086 | 1 132 645 | |
2018-10-01 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 57 | 18 504 | 0,31 | 75,26 | 4 290 | 1 392 611 | |
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −12 000 | 12 800 | −48,39 | ||||
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −1 560 | 1 560 | −50,00 | ||||
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 0 | −100,00 | ||||
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −4 000 | 18 447 | −17,82 | 79,73 | −318 920 | 1 470 779 | |
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −9 133 | 22 447 | −28,92 | 80,40 | −734 293 | 1 804 739 | |
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 12 000 | 31 580 | 61,29 | 51,30 | 615 600 | 1 620 054 | |
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 106 | 19 580 | −5,35 | 80,40 | −88 922 | 1 574 232 | |
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 560 | 20 686 | 8,16 | 44,90 | 70 044 | 928 801 | |
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 221 | 19 126 | −6,00 | 80,40 | −98 168 | 1 537 730 | |
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 20 347 | 10,90 | 32,93 | 65 860 | 670 027 | |
2018-07-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 62 | 18 347 | 0,34 | 69,54 | 4 311 | 1 275 850 | |
2018-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −650 | 650 | −50,00 | ||||
2018-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 0 | −100,00 | ||||
2018-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −221 | 18 285 | −1,19 | 69,03 | −15 256 | 1 262 214 | |
2018-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 650 | 18 506 | 3,64 | ||||
2018-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −272 | 17 856 | −1,50 | 69,03 | −18 776 | 1 232 600 | |
2018-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 18 128 | 4,62 | ||||
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −4 680 | 3 120 | −60,00 | ||||
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | 100 | 100 | |||||
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | 100 | 100 | |||||
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −100 | 17 328 | −0,57 | ||||
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −100 | 17 328 | −0,57 | ||||
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 000 | 17 528 | −10,24 | 65,58 | −131 160 | 1 149 486 | |
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −3 717 | 19 528 | −15,99 | 65,25 | −242 534 | 1 274 202 | |
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 4 680 | 23 245 | 25,21 | 44,90 | 210 132 | 1 043 700 | |
2018-04-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 184 | 18 565 | 1,00 | 60,16 | 11 069 | 1 116 870 | |
2018-03-05 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 27 000 | 27 000 | |||||
2018-03-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −350 | 700 | −33,33 | ||||
2018-03-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −1 025 | 1 025 | −50,00 | ||||
2018-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −116 | 18 381 | −0,63 | 59,96 | −6 955 | 1 102 125 | |
2018-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 350 | 18 497 | 1,93 | ||||
2018-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −352 | 18 147 | −1,90 | 59,96 | −21 106 | 1 088 094 | |
2018-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 025 | 18 499 | 5,87 | ||||
2018-02-05 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 2 000 | −50,00 | ||||
2018-02-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 419 | 17 474 | −7,51 | 63,21 | −89 695 | 1 104 532 | |
2018-02-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 18 893 | 11,84 | 32,93 | 65 860 | 622 146 | |
2018-01-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 87 | 16 893 | 0,52 | 48,42 | 4 213 | 817 959 | |
2017-12-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −50 | 16 806 | −0,30 | ||||
2017-12-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −250 | 16 856 | −1,46 | ||||
2017-10-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 84 | 17 106 | 0,49 | 49,85 | 4 187 | 852 734 | |
2017-07-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 87 | 17 022 | 0,51 | 48,39 | 4 210 | 823 695 | |
2017-06-05 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −4 000 | 4 000 | −50,00 | ||||
2017-06-05 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 0 | −100,00 | ||||
2017-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −3 068 | 16 935 | −15,34 | 52,26 | −160 334 | 885 023 | |
2017-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 4 000 | 20 003 | 25,00 | 32,93 | 131 720 | 658 699 | |
2017-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 369 | 16 003 | −7,88 | 52,26 | −71 544 | 836 317 | |
2017-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 17 372 | 13,01 | 26,09 | 52 180 | 453 235 | |
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −650 | 1 300 | −33,33 | ||||
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 800 | −50,00 | ||||
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 800 | −50,00 | ||||
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −241 | 15 372 | −1,54 | 51,90 | −12 508 | 797 807 | |
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 650 | 15 613 | 4,34 | ||||
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −296 | 14 963 | −1,94 | 51,90 | −15 362 | 776 580 | |
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −296 | 14 963 | −1,94 | 51,90 | −15 362 | 776 580 | |
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 15 259 | 5,53 | ||||
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 15 259 | 5,53 | ||||
2017-05-16 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −500 | 13 955 | −3,46 | 51,00 | −25 500 | 711 705 | |
2017-05-16 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 500 | 14 455 | −14,74 | 51,26 | −128 161 | 741 027 | |
2017-04-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 249 | 16 955 | 1,49 | 42,19 | 10 505 | 715 331 | |
2017-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 25 000 | 25 000 | |||||
2017-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −350 | 1 050 | −25,00 | ||||
2017-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −1 025 | 2 050 | −33,33 | ||||
2017-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −148 | 16 706 | −0,88 | 41,93 | −6 206 | 700 483 | |
2017-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 350 | 16 854 | 2,12 | ||||
2017-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −434 | 16 504 | −2,56 | 41,93 | −18 198 | 692 013 | |
2017-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 025 | 16 938 | 6,44 | ||||
2017-01-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 98 | 15 913 | 0,62 | 41,96 | 4 112 | 667 709 | |
2016-11-09 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −475 | 15 815 | −2,92 | ||||
2016-11-09 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −300 | 16 290 | −1,81 | 41,79 | −12 537 | 680 775 | |
2016-11-09 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −1 200 | 16 590 | −6,75 | 41,77 | −50 125 | 692 981 | |
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 555 | 17 790 | −12,56 | 40,40 | −103 222 | 718 716 | |
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −4 000 | 2 000 | −66,67 | ||||
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −4 000 | 2 000 | −66,67 | ||||
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 0 | −100,00 | ||||
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −3 158 | 20 345 | −13,44 | 39,18 | −123 730 | 797 117 | |
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 4 000 | 23 503 | 20,51 | 26,09 | 104 360 | 613 193 | |
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −3 257 | 19 503 | −14,31 | 39,18 | −127 609 | 764 128 | |
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 4 000 | 22 760 | 21,32 | 27,63 | 110 520 | 628 859 | |
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 360 | 18 760 | −6,76 | 39,18 | −53 285 | 735 017 | |
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 20 120 | 11,04 | 19,26 | 38 520 | 387 511 | |
2016-10-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 116 | 18 120 | 0,64 | 38,06 | 4 415 | 689 647 | |
2016-07-01 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 91 | 18 004 | 0,51 | 45,34 | 4 126 | 816 301 | |
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −650 | 1 950 | −25,00 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 1 600 | −33,33 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 1 600 | −33,33 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 800 | −50,00 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −241 | 17 913 | −1,33 | 41,06 | −9 895 | 735 508 | |
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 650 | 18 154 | 3,71 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 17 504 | 4,79 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 17 504 | 4,79 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 17 504 | 4,79 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −296 | 16 704 | −1,74 | 41,06 | −12 154 | 685 866 | |
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −296 | 16 704 | −1,74 | 41,06 | −12 154 | 685 866 | |
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −296 | 16 704 | −1,74 | 41,06 | −12 154 | 685 866 | |
2016-04-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 223 | 15 992 | 1,41 | 39,84 | 8 884 | 637 121 | |
2016-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 27 100 | 27 100 | |||||
2016-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 1 400 | 1 400 | |||||
2016-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −1 025 | 3 075 | −25,00 | ||||
2016-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −350 | 15 769 | −2,17 | ||||
2016-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −434 | 16 119 | −2,62 | 39,87 | −17 304 | 642 665 | |
2016-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 025 | 16 553 | 6,60 | ||||
2016-01-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 96 | 15 528 | 0,62 | 41,85 | 4 018 | 649 847 | |
2015-10-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 89 | 15 432 | 0,58 | 45,35 | 4 036 | 699 841 | |
2015-07-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 72 | 15 343 | 0,47 | 55,36 | 3 986 | 849 335 | |
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −650 | 2 600 | −20,00 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 2 400 | −25,00 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 2 400 | −25,00 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 1 600 | −33,33 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 800 | −50,00 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −235 | 15 271 | −1,52 | 55,70 | −13 090 | 850 595 | |
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 650 | 15 506 | 4,38 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 14 856 | −1,91 | 55,70 | −16 097 | 827 479 | |
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 14 856 | −1,91 | 55,70 | −16 097 | 827 479 | |
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 14 856 | −1,91 | 55,70 | −16 097 | 827 479 | |
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 14 856 | −1,91 | 55,70 | −16 097 | 827 479 | |
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 15 145 | 5,58 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 15 145 | 5,58 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 15 145 | 5,58 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 15 145 | 5,58 | ||||
2015-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 244 | 12 812 | 1,94 | 47,97 | 11 704 | 614 534 | |
2015-03-11 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −120 | 12 568 | −0,95 | 50,60 | −6 072 | 635 941 | |
2015-03-03 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
A - Award | 24 800 | 24 800 | |||||
2015-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 4 100 | 4 100 | |||||
2015-01-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 94 | 12 688 | 0,75 | 42,71 | 4 015 | 541 930 | |
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 8 000 | −20,00 | ||||
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 8 000 | −20,00 | ||||
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 6 000 | −25,00 | ||||
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 689 | 12 594 | −11,83 | 43,54 | −73 539 | 548 343 | |
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 14 283 | 16,28 | 32,93 | 65 860 | 470 339 | |
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 489 | 12 283 | −10,81 | 43,54 | −64 831 | 534 802 | |
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 13 772 | 16,99 | 26,09 | 52 180 | 359 311 | |
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 534 | 11 772 | −11,53 | 43,54 | −66 790 | 512 553 | |
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 13 306 | 17,69 | 27,63 | 55 260 | 367 645 | |
2014-11-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −250 | 11 306 | −2,16 | ||||
2014-10-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 114 | 11 556 | 1,00 | 35,00 | 3 990 | 404 437 | |
2014-07-31 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 2 000 | −50,00 | ||||
2014-07-31 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 2 000 | −50,00 | ||||
2014-07-31 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 348 | 11 442 | −10,54 | 39,38 | −53 084 | 450 586 | |
2014-07-31 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 12 790 | 18,54 | 19,26 | 38 520 | 246 335 | |
2014-07-31 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 256 | 10 790 | −10,43 | 39,38 | −49 461 | 424 910 | |
2014-07-31 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 12 046 | 19,91 | 16,46 | 32 920 | 198 277 | |
2014-07-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 94 | 10 046 | 0,94 | 41,94 | 3 943 | 421 354 | |
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
A - Award | 7 800 | 7 800 | |||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 3 250 | 3 250 | |||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 3 200 | −20,00 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 3 200 | −20,00 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 2 400 | −25,00 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 1 600 | −33,33 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 800 | −50,00 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 9 952 | −2,82 | 44,90 | −12 976 | 446 845 | |
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 9 952 | −2,82 | 44,90 | −12 976 | 446 845 | |
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 10 241 | 8,47 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 10 241 | 8,47 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 9 441 | −2,97 | 44,90 | −12 976 | 423 901 | |
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 9 730 | 8,96 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 8 930 | −3,13 | 44,90 | −12 976 | 400 957 | |
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 9 219 | 9,50 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 8 419 | −3,32 | 44,90 | −12 976 | 378 013 | |
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 8 708 | 10,12 | ||||
2014-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 276 | 7 397 | 3,88 | 41,28 | 11 393 | 305 330 | |
2014-01-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 58 | 7 121 | 0,82 | 40,38 | 2 342 | 287 510 | |
2013-11-22 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −85 | 7 063 | −1,19 | ||||
2013-10-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −390 | 7 148 | −5,17 | ||||
2013-10-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 72 | 7 538 | 0,96 | 32,26 | 2 323 | 243 191 | |
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 6 000 | −25,00 | ||||
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 6 000 | −25,00 | ||||
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 793 | 7 466 | −19,36 | 33,03 | −59 223 | 246 602 | |
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 9 259 | 27,55 | 27,63 | 55 260 | 255 826 | |
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 757 | 7 259 | −19,49 | 33,03 | −58 034 | 239 765 | |
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 9 016 | 28,51 | 26,69 | 53 380 | 240 637 | |
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −9 401 | 7 016 | −57,26 | 33,03 | −310 515 | 231 738 | |
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 10 000 | 16 417 | 155,84 | 29,92 | 299 200 | 491 197 | |
2013-07-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 77 | 6 417 | 1,21 | 29,68 | 2 285 | 190 444 | |
2013-06-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −600 | 6 340 | −8,65 | 32,43 | −19 458 | 205 606 | |
2013-06-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −1 400 | 6 940 | −16,79 | 32,41 | −45 374 | 224 925 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 8 000 | −20,00 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 8 000 | −20,00 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 8 000 | −20,00 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 4 000 | −33,33 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 728 | 8 340 | −17,16 | 33,20 | −57 370 | 276 888 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 10 068 | 24,79 | 26,09 | 52 180 | 262 674 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 787 | 8 068 | −18,13 | 33,20 | −59 328 | 267 858 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 9 855 | 25,46 | 27,63 | 55 260 | 272 294 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 466 | 7 855 | −15,73 | 33,20 | −48 671 | 260 786 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 9 321 | 27,32 | 19,26 | 38 520 | 179 522 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 358 | 7 321 | −15,65 | 33,20 | −45 086 | 243 057 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 8 679 | 29,94 | 16,46 | 32 920 | 142 856 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
A - Award | 10 000 | 10 000 | |||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 4 000 | 4 000 | |||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 3 200 | −20,00 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 3 200 | −20,00 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 2 400 | −25,00 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 1 600 | −33,33 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 800 | −50,00 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 6 679 | −4,16 | 32,93 | −9 550 | 219 939 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 6 679 | −4,16 | 32,93 | −9 550 | 219 939 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 6 969 | 12,97 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 6 459 | 14,14 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 5 659 | −4,87 | 32,93 | −9 550 | 186 351 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 5 949 | 15,54 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 5 149 | −5,33 | 32,93 | −9 550 | 169 557 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 5 439 | 17,25 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 4 639 | −5,88 | 32,93 | −9 550 | 152 762 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 4 929 | 19,38 | ||||
2013-05-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 000 | 4 129 | −32,63 | 33,41 | −66 820 | 137 951 | |
2013-05-30 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −15 000 | 0 | −100,00 | ||||
2013-05-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −15 000 | 6 129 | −70,99 | 34,00 | −510 008 | 208 389 | |
2013-05-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 15 000 | 21 129 | 244,74 | 31,40 | 471 000 | 663 451 | |
2013-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 234 | 6 129 | 3,97 | 32,36 | 7 572 | 198 316 | |
2013-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 000 | 5 895 | −25,33 | 30,89 | −61 781 | 182 099 | |
2013-02-20 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −8 000 | 2 000 | −80,00 | ||||
2013-02-20 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −7 328 | 7 895 | −48,14 | 30,74 | −225 263 | 242 692 | |
2013-02-20 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 8 000 | 15 223 | 110,76 | 26,69 | 213 520 | 406 302 | |
2013-01-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 85 | 7 223 | 1,19 | 26,55 | 2 257 | 191 789 | |
2012-12-12 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2012-12-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −10 000 | 7 138 | −58,35 | 28,03 | −280 301 | 200 079 | |
2012-12-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 10 000 | 17 138 | 140,10 | 25,03 | 250 300 | 428 964 | |
2012-12-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −288 | 7 138 | −3,88 | ||||
2012-10-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 84 | 7 426 | 1,14 | 27,08 | 2 274 | 201 059 | |
2012-07-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 84 | 7 342 | 1,16 | 26,29 | 2 208 | 192 995 | |
2012-06-18 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −3 000 | 7 258 | −29,25 | 27,00 | −81 000 | 195 966 | |
2012-06-08 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 6 000 | −25,00 | ||||
2012-06-08 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 6 000 | −25,00 | ||||
2012-06-08 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 640 | 10 258 | −13,78 | 26,85 | −44 034 | 275 427 | |
2012-06-08 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 11 898 | 20,21 | 19,26 | 38 520 | 229 155 | |
2012-06-08 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 508 | 9 898 | −13,22 | 26,85 | −40 490 | 265 761 | |
2012-06-08 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 11 406 | 21,26 | 16,46 | 32 920 | 187 743 | |
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
A - Award | 10 000 | 10 000 | |||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 4 000 | 4 000 | |||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 3 200 | −20,00 | ||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 3 200 | −20,00 | ||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 2 400 | −25,00 | ||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 1 600 | −33,33 | ||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 9 406 | −2,99 | 26,09 | −7 566 | 245 403 | |
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 9 406 | −2,99 | 26,09 | −7 566 | 245 403 | |
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 9 406 | −2,99 | 26,09 | −7 566 | 245 403 | |
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 9 696 | 8,99 | ||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 9 696 | 8,99 | ||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 9 696 | 8,99 | ||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 8 896 | −3,16 | 26,09 | −7 566 | 232 097 | |
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 9 186 | 9,54 | ||||
2012-05-18 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 0 | −100,00 | ||||
2012-05-18 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 7 366 | −3,79 | 27,24 | −7 900 | 200 650 | |
2012-05-18 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 7 656 | 11,67 | ||||
2012-04-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 289 | 6 856 | 4,40 | 28,38 | 8 201 | 194 549 | |
2012-03-19 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −51 | 6 567 | −0,77 | 29,74 | −1 517 | 195 303 | |
2012-03-15 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −2 906 | 0 | −100,00 | ||||
2012-03-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 906 | 6 618 | −30,51 | 29,45 | −85 582 | 194 900 | |
2012-03-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 906 | 9 524 | 43,91 | 25,89 | 75 236 | 246 576 | |
2012-03-12 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −3 256 | 2 906 | −52,84 | ||||
2012-03-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −3 256 | 6 618 | −32,98 | 29,94 | −97 481 | 198 136 | |
2012-03-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 3 256 | 9 874 | 49,20 | 25,89 | 84 298 | 255 638 | |
2012-03-12 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −3 838 | 6 162 | −38,38 | ||||
2012-03-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −3 838 | 6 618 | −36,71 | 29,50 | −113 221 | 195 231 | |
2012-03-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 3 838 | 10 456 | 57,99 | 25,89 | 99 366 | 270 706 | |
2012-03-05 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 8 000 | −20,00 | ||||
2012-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 571 | 6 618 | −19,18 | 29,04 | −45 622 | 192 187 | |
2012-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 8 189 | 32,32 | 19,26 | 38 520 | 157 720 | |
2012-01-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 86 | 6 189 | 1,41 | 24,39 | 2 097 | 150 928 | |
2008-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 256 | 1 689 | 17,86 | 24,36 | 6 236 | 41 144 |